73 consecutive patients were monitored and submitted to ambulatorial screening for primary infertility. In all of them was also performed a study of the BBT behaviour and the results reported on a graph. All these with LUF syndrome had substantial deviation of the BBT graphs. This observation can make us obtain a new parameter and a first diagnostic approach in the study of the ovulatory infertility.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Luteinised unruptured follicle syndrome: pathophysiological background and new target therapy in assisted reproductive treatments.
J Obstet Gynaecol
November 2022
Department of Obstetrics and Gynecology, Villa Sofia Cervello Hospital, IVF Unit, University of Palermo, Palermo, Italy.
Luteinised unruptured follicle syndrome (LUFS) is a cause of infertility consisting in the unruptured of the dominant follicle after the LH-surge. In fact, during assisted reproductive treatments (ART) clomiphene citrate and letrozole are frequently administered in order to achieve ovulation. However, considering the pathophysiology of LUFS, new possible therapy can be proposed.
View Article and Find Full Text PDFThe mare as a model for luteinized unruptured follicle syndrome: intrafollicular endocrine milieu.
Reproduction
March 2016
Department of Animal ScienceFood and Nutrition, Southern Illinois University, 1205 Lincoln Drive, MC 4417, Carbondale, Illinois 62901, USAEquiBreed OzWarnervale, New South Wales, AustraliaDepartment of PhysiologySouthern Illinois University, Carbondale, Illinois, USADepartamento de Medicina y Cirugía AnimalFacultad de Veterinaria, Universidad CEU Cardenal Herrera, Valencia, SpainDepartment of ObstetricsGynecology and Reproductive Sciences, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Luteinized unruptured follicle (LUF) syndrome is a recurrent anovulatory dysfunction that affects up to 23% of women with normal menstrual cycles and up to 73% with endometriosis. Mechanisms underlying the development of LUF syndrome in mares were studied to provide a potential model for human anovulation. The effect of extended increase in circulating LH achieved by administration of recombinant equine LH (reLH) or a short surge of LH and decrease in progesterone induced by prostaglandin F2α (PGF2α) on LUF formation (Experiment 1), identification of an optimal dose of COX-2 inhibitor (flunixin meglumine, FM; to block the effect of prostaglandins) for inducing LUFs (Experiment 2), and evaluation of intrafollicular endocrine milieu in LUFs (Experiment 3) were investigated.
View Article and Find Full Text PDFLuteinized unruptured follicle (LUF) syndrome is one of the intractable ovulation disorders that are commonly observed during cycles of treatment with ovulation inducers, for which no effective therapy other than assisted reproductive technology is available. Here, we investigated whether granulocyte colony-stimulating factor (G-CSF) could prevent the onset of LUF syndrome. We analyzed the effects of G-CSF in 68 infertile women with LUF syndrome who received ovulation induction (clomiphene + human chorionic gonadotropin [hCG] therapy or follicle-stimulating hormone + hCG therapy).
View Article and Find Full Text PDFEndometriotic disease: the role of peritoneal fluid.
Hum Reprod Update
April 1999
Department of Obstetrics and Gynaecology, University Hospital Gasthuisberg, K.U. Leuven, Belgium.
Peritoneal fluid and the intraovarian milieu are a specific microenvironment. Peritoneal fluid originates mainly as an ovarian exudation product caused by increased vascular permeability, with cyclic variation in volume and steroid hormones which are always higher than in plasma. It contains large amounts of macrophages and their secretion products, and has a large exchange area with plasma through the peritoneum, which is highly permeable for small molecules.
View Article and Find Full Text PDFComplete and partial luteinized unruptured follicle syndrome after ovarian stimulation with clomiphene citrate/human menopausal gonadotrophin/human chorionic gonadotrophin.
Hum Reprod
March 1996
Department of Obstetrics and Gynaecology, University Hospital, Ghent, Belgium.
A total of 31 clomiphene citrate/human menopausal gonadotrophin (HMG)/human chorionic gonadotrophin (HCG)-stimulated cycles in 28 patients were investigated to determine the fate of each of the matured follicles. A standard stimulation regimen was adhered to, and ultrasound as well as hormonal monitoring was performed. All follicles were measured by vaginal ultrasound at -12, +35 and +45 h relative to HCG administration and at 7 days after HCG administration.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!